|

The ATtune Knee Outcome Study

RECRUITINGSponsored by Spaarne Gasthuis
Actively Recruiting
SponsorSpaarne Gasthuis
Started2020-02-03
Est. completion2024-01-22
Eligibility
Age21 Years – 90 Years
View on ClinicalTrials.gov →

NCT04247672

Summary

To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. There have been no studies reporting on the results of the uncemented version of the ATTUNE. Therefore, the main objective of the current study was to report patient reported outcome measures (PROMs), survivorship and complications associated with the uncemented ATTUNE TKA.

Eligibility

Age: 21 Years – 90 Years
Inclusion Criteria:

* End-stage osteoarthritis of the knee warranting joint replacement therapy.
* Indicated for an ATTUNE total knee system as part of regular clinical practice.
* Capability and willingness to sign informed consent and comply with follow-up procedures.
* Capable enough in Dutch or English to be able to understand study procedures

Exclusion Criteria:

* Unable or unwilling to sign informed consent and comply with follow-up
* Indication for primary revision arthroplasty
* Absolute indication for cemented fixation (decreased bone stock/quality of spongiosa)

Conditions5

ArthritisKnee OsteoarthritisKnee RheumatismOsteoarthritis, KneeRheumatoid Arthritis

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.